국내？외 허가사항, 교과서, 가이드라인, 임상연구문헌, 관련 학회 의견 등을 참고하여, 경피적관상동맥중재술에서 no-reflow가 발생한 경우 및 관상동맥내 압력측정술 시 최대충혈 유도를 위해 관상동맥주입에 요양급여 인정하여 급여기준을 신설함.
■ 관련문헌 등
？ Myocardial Infarction: A Companion of Braunwald’s Heart Disease 1e (2016) > CHAPTER 17. Approach to Percutaneous Coronary Intervention in Myocardial Infarction
？ Textbook of Interventional Cardiology 8e (2019) > CHAPTER 27. Bypass Graft Intervention
？ 일조각, 순환기학 제2판(2010) > 제22장. 관상동맥의 생리학적 검사
？ ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction (2013)
？ 대한심혈관중재학회, 심혈관중재매뉴얼 (2016)
？ LW Klein et al. Society of Cardiac Angiography and Interventions: Suggested Management of the no-reflow Phenomenon in the Cardiac Catheterization Laboratory. Catheterization and Cardiovascular Interventions 2006;60:194？201
？ 군자출판사, SNUH 심혈관 진료 매뉴얼(2014)
？ Gabor G et al. Standardization of Fractional Flow Reserve Measurements. JACC 2016;68(7) 742-53
？ Interventional Cardiac Catheterization Handbook 4e (2018)
？ N Geng et al. Clinical outcomes of nicorandil administration in patients with acute ST？segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a systematic review and meta？analysis of randomized controlled trials. BMC Cardiovascular disorders 2021 oct;21(1):488
？ 안성규 외. 급성 심근경색증 환자에서 관동맥 중재 시술 전에 관동맥 내 Nicorandil 투여 효과. Korean Circ J 2008;38:95-100
？ Q Qi et al. Intracoronary Nicorandil and the Prevention of the no-reflow Phenomenon During Primary Percutaneous Coronary Intervention in Patients with Acute ST-Segment Elevation Myocardial Infarction. Med sci Monit. 2018 May;4(24):2767-76
？ D Kato et al. Feasibility and safety of intracoronary nicorandil infusion as a novel hyperemic agent for fractional flow reserve measurements. Heart Vessels 2015 jul;30(4):477-83
？ HJ Jang et al. Safety and efficacy of a novel hyperaemic agent, intracoronary nicorandil, for invasive physiological assessments in the cardiac catheterization laboratory. European Heart Journal (2013) 34, 2055？2062